Indication
Gout Arthritis
2 clinical trials
14 products
Product
Dose-5Product
Dose-1Product
Dose-2 GroupClinical trial
A Randomized, Open-label,Single Dosing Clinical Trail to Investigate the Pharmacokinetic/Pharmacodynamic Characteristics of IBI128 in Chinese Healthy SubjectsStatus: Completed, Estimated PCD: 2024-03-16
Product
ColchicineProduct
Dose-4 GroupProduct
Dose-3Clinical trial
A Randomized, Open-label, Active-Controlled Phase II Trial to Evaluate the Efficacy and Safety of SSGJ-613 for Prophylaxis Against Acute Gouty Arthritis Flares in Subjects Initiating Urate-Lowering Treatment.Status: Recruiting, Estimated PCD: 2024-06-01
Product
dose-3Product
Dose-1 GroupProduct
Dose-2Product
Dose-4Product
Dose-3 GroupProduct
DOSE-3Product
Recombinant Anti-IL-1β